CLIMB BIO, INC. Earnings Per Share (Diluted)
CLIMB BIO, INC. (CLYM) reported Earnings Per Share (Diluted) of -$0.18 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- CLIMB BIO, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.18.
- CLIMB BIO, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.20.
- CLIMB BIO, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.26.
- CLIMB BIO, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.19.
- CLIMB BIO, INC. earnings per share, diluted for fiscal 2025 was -$0.88.
- CLIMB BIO, INC. earnings per share, diluted for fiscal 2024 was -$1.53.
- CLIMB BIO, INC. earnings per share, diluted for fiscal 2023 was -$1.30.
- CLIMB BIO, INC. earnings per share, diluted for fiscal 2022 was -$1.72.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.18 10-Q · filed 2026-08-06 | -$0.38 10-Q · filed 2026-08-06 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-07 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.88 10-K · filed 2026-03-05 | ||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-06 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.63 10-Q · filed 2025-11-06 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.13 10-Q · filed 2026-08-06 | -$0.44 10-Q · filed 2026-08-06 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-03-31 | -$0.31 10-Q · filed 2026-05-07 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2024-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.53 10-K · filed 2026-03-05 | ||
| 2024-09-30 | -$0.13 10-Q · filed 2025-11-06 | -$1.31 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.57 10-Q · filed 2025-11-06 | -$1.81 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-06-30 | -$1.81 10-Q · filed 2025-08-12 | -$1.95 10-Q · filed 2025-08-12 | -$2.11 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$2.28 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-03-31 | -$0.06 10-Q · filed 2025-05-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2023-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$0.28 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-03-25 | -$1.30 10-K · filed 2025-03-25 | ||
| 2023-09-30 | -$0.15 10-Q · filed 2024-11-12 | -$0.34 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.17 10-Q · filed 2024-11-12 | -$1.47 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$0.19 10-Q · filed 2024-08-14 | -$1.03 10-Q · filed 2024-08-14 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$1.70 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||
| 2023-03-31 | -$0.84 10-Q · filed 2024-05-15 | -$1.14 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$2.06 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||
| 2022-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.72 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$0.37 10-Q · filed 2023-11-14 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.43 10-Q · filed 2023-11-14 | -$1.83 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.37 10-Q · filed 2023-11-14 | -$0.56 10-Q · filed 2022-08-15 | -$1.43 10-Q · filed 2023-11-14 | -$1.06 10-Q · filed 2022-08-15 | -$1.46 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$2.03 derived: net income ÷ weighted average shares · filed 2023-08-10 |
| 2022-03-31 | -$0.50 10-Q · filed 2023-05-11 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2.35 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||
| 2021-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$4.24 10-K · filed 2023-03-06 | ||
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-14 | -$1.92 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$5.49 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$3.11 10-Q · filed 2022-08-15 | -$8.80 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | -$5.38 derived: net income ÷ weighted average shares · filed 2022-05-16 | |||||
| 2020-12-31 | -$9.45 derived: net income ÷ weighted average shares · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |